A rare case of recurrent ovarian cancer with TPM3-NTRK1 gene rearrangement: A case report

NTRK gene fusion is rare in gynecological cancer. Entrectinib is a novel targeted drug, which is a potent inhibitor of TRK A, B and C. The present case report described a case of recurrent ovarian cancer with TPM3-NTRK1 rearrangement, which was detected by next-generation sequencing (NGS) and treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Endo, Yuta, Watanabe, Takafumi, Saito, Motonobu, Saito, Katsuharu, Suzuki, Rei, Sano, Hideki, Natori, Yutaka, Sasaki, Eisaku, Ueda, Makiko, Kamo, Norihito, Furukawa, Shigenori, Soeda, Shu, Kono, Koji, Saji, Shigehira, Fujimori, Keiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892455/
https://www.ncbi.nlm.nih.gov/pubmed/35251641
http://dx.doi.org/10.3892/mco.2022.2523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892455/
https://www.ncbi.nlm.nih.gov/pubmed/35251641
http://dx.doi.org/10.3892/mco.2022.2523

Ejemplares similares